Washington, Jan 30 (ANI): Researchers at the University of Notre Dame and the Washington University School of Medicine have made a major advance in using a synthetic probe to target dead and dying cells in mammary and prostate tumours in living animals.

The feat has taken the researchers a step closer to developing an effective method to image cell death as a means to intervene early in diseases and rapidly determine the effectiveness of treatments.

Bradley D. Smith, Emil T. Hofman Professor of Chemistry and Biochemistry at Notre Dame, points out that the group of researchers had previously discovered that synthetic zinc (II)-dipicolylamine (Zn-DPA) coordination complexes can selectively target the outer surfaces of anionic (negatively charged) cell membranes.

In addition, fluorescent versions of these Zn-DPA complexes act as imaging probes that can distinguish dead and dying mammalian cells from healthy cells in a cell culture and also selectively target bacteria in contaminated samples.

The researchers also recently demonstrated that a fluorescent near-infrared probe referred to as PSS-794 could be used to image bacterial infections in mice.

They indicated that PSS-794 has a notable ability to selectively target anionic cells in living animals.

In the new paper, the researchers describe a significant expansion of the animal imaging capability of PSS-794 by showing that it can target the anionic dead and dying cells within tumours in rat and mouse models.

The research is an important step toward the development of optical imaging probes that could determine, noninvasively, the amount and type of cell death in tumours.

Such imaging techniques could help clinicians accurately determine the grade of tumours and the stage of cancers, as well as to measure the effectiveness of treatments.

The researchers also believe that analogous probes can be developed that would allow for deep tissue imaging of cancers in humans.

Smith points out that although the study focused on mammary and prostate tumours, imaging of cell death is broadly useful for treatment of numerous conditions, including cardiovascular disease, neurology, renal disease and even transplant rejection. (ANI)